Edwards Lifesciences (WBO:EWLS) Cyclically Adjusted Book per Share: €8.85 (As of Mar. 2026)


WBO:EWLS Edwards Lifesciences Corp WBO:EWLS
96 GF Score
Price €80.12
GF Value €82.70
Valuation Fairly Valued
! 5 Warning Signs
View Full Analysis

What is Edwards Lifesciences Cyclically Adjusted Book per Share?

Edwards Lifesciences WBO:EWLS -0.55% 96 Cyclically Adjusted Book per Share is €8.85 as of Mar. 2026. GuruFocus rates WBO:EWLS with a GF Score™ of 96/100 and a GF Value™ of €82.70 (Fairly Valued). The stock has 5 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

Edwards Lifesciences's adjusted book value per share for the three months ended in Mar. 2026 was €15.482. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is €8.85 for the trailing ten years ended in Mar. 2026.

During the past 12 months, Edwards Lifesciences's average Cyclically Adjusted Book Growth Rate was 18.00% per year. During the past 3 years, the average Cyclically Adjusted Book Growth Rate was 17.20% per year. During the past 5 years, the average Cyclically Adjusted Book Growth Rate was 18.40% per year. During the past 10 years, the average Cyclically Adjusted Book Growth Rate was 17.00% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Book Growth Rate using Cyclically Adjusted Book per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Book Growth Rate of Edwards Lifesciences was 19.30% per year. The lowest was 11.30% per year. And the median was 15.25% per year.

As of today (2026-06-29), Edwards Lifesciences's current stock price is €80.12. Edwards Lifesciences's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2026 was €8.85. Edwards Lifesciences's Cyclically Adjusted PB Ratio of today is 9.05.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Edwards Lifesciences was 26.56. The lowest was 7.52. And the median was 15.28.


Edwards Lifesciences  (WBO:EWLS) Cyclically Adjusted Book per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Book per Share may underestimate the company's equity. Cyclically Adjusted PB Ratio can seem to be too high even the actual PB Ratio is low.

For the Cyclically Adjusted PB Ratio, the book value of the past 10 years are inflation-adjusted and averaged. The result is used for P/B calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PB Ratio is also called CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Edwards Lifesciences's Cyclically Adjusted PB Ratio of today is calculated as

Cyclically Adjusted PB Ratio=Share Price/Cyclically Adjusted Book per Share
=80.12/8.85
=9.05

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Edwards Lifesciences was 26.56. The lowest was 7.52. And the median was 15.28.


Be Aware

Cyclically Adjusted PB Ratio works better for cyclical companies. It gives you a better idea on the company's real book value.


Edwards Lifesciences Cyclically Adjusted Book per Share Related Terms


Edwards Lifesciences Cyclically Adjusted Book per Share Historical Data

* Premium members only.

The historical data trend for Edwards Lifesciences's Cyclically Adjusted Book per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Edwards Lifesciences Cyclically Adjusted Book per Share Chart

Edwards Lifesciences Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted Book per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 4.55 5.77 6.45 8.18 8.52

Edwards Lifesciences Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Cyclically Adjusted Book per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 8.06 7.79 8.10 8.52 8.85

WBO:EWLS vs BSX, GEHC, DXCM: Cyclically Adjusted Book per Share Comparison

For the Medical Devices subindustry, Edwards Lifesciences's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Edwards Lifesciences Cyclically Adjusted PB Ratio vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Edwards Lifesciences's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Edwards Lifesciences's Cyclically Adjusted PB Ratio falls into.


WBO:EWLS
96GF Score
Edwards Lifesciences Corp WBO:EWLS
Cyclically Adjusted Book per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Edwards Lifesciences Cyclically Adjusted Book per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

What is Cyclically Adjusted Book per Share? How do we calculate Cyclically Adjusted Book per Share?

Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Book per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the book value per share from 2001 through 2010.

We adjusted the 2001 book value per share data with the total inflation from 2001 through 2010 to the equivalent book value in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's book value is $1 a share in 2001, then the 2001's equivalent book value in 2010 is $1.4 a share. If Wal-Mart's book value is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 book value in 2010 is $1.35. So on and so forth, you get the equivalent book value per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Edwards Lifesciences's adjusted Book Value per Share data for the three months ended in Mar. 2026 was:

Adj_Book= Book Value per Share /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=15.482/330.2130*330.2130
=15.482

Current CPI (Mar. 2026) = 330.2130.

Edwards Lifesciences Quarterly Data

Book Value per Share CPI Adj_Book
201606 3.447 241.018 4.723
201609 3.741 241.428 5.117
201612 3.911 241.432 5.349
201703 4.063 243.801 5.503
201706 4.131 244.955 5.569
201709 4.180 246.819 5.592
201712 3.971 246.524 5.319
201803 4.164 249.554 5.510
201806 4.316 251.989 5.656
201809 4.592 252.439 6.007
201812 4.430 251.233 5.823
201903 4.880 254.202 6.339
201906 4.967 256.143 6.403
201909 5.538 256.759 7.122
201912 5.952 256.974 7.648
202003 5.699 258.115 7.291
202006 5.486 257.797 7.027
202009 5.739 260.280 7.281
202012 6.023 260.474 7.636
202103 6.293 264.877 7.845
202106 6.838 271.696 8.311
202109 7.546 274.310 9.084
202112 8.276 278.802 9.802
202203 8.541 287.504 9.810
202206 9.072 296.311 10.110
202209 10.139 296.808 11.280
202212 9.011 296.797 10.026
202303 9.214 301.836 10.080
202306 9.680 305.109 10.476
202309 10.285 307.789 11.034
202312 10.145 306.746 10.921
202403 10.871 312.332 11.493
202406 11.472 314.175 12.058
202409 14.582 315.301 15.272
202412 16.222 315.605 16.973
202503 15.983 319.799 16.503
202506 15.552 322.561 15.921
202509 14.973 324.800 15.223
202512 15.203 324.054 15.492
202603 15.482 330.213 15.482

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

What does a Cyclically Adjusted Book per Share of €8.85 mean?
Edwards Lifesciences (WBO:EWLS) has a Cyclically Adjusted Book per Share of €8.85 as of Mar. 2026. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on Edwards Lifesciences and its competitors.
Is Edwards Lifesciences' Cyclically Adjusted Book per Share too high?
Edwards Lifesciences' current Cyclically Adjusted Book per Share is €8.85. Overall, Edwards Lifesciences has a GF Score™ of 96/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Edwards Lifesciences' Cyclically Adjusted Book per Share compare to BSX and GEHC?
Edwards Lifesciences' Cyclically Adjusted Book per Share of €8.85 can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Book per Share for a Medical Devices & Instruments company?
A good Cyclically Adjusted Book per Share depends on the Medical Devices & Instruments industry context. However, Cyclically Adjusted Book per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Book per Share mean?
A high Cyclically Adjusted Book per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on Edwards Lifesciences and its competitors. Edwards Lifesciences's current Cyclically Adjusted Book per Share is €8.85. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Edwards Lifesciences stock overvalued right now?
Based on GuruFocus' analysis, Edwards Lifesciences (WBO:EWLS) is currently considered Fairly Valued. The stock's GF Value™ is €82.70, compared to a current price of €80.12 — trading 3.1% below its estimated fair value. The current Cyclically Adjusted Book per Share is €8.85. Edwards Lifesciences' overall GF Score™ is 96/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Book per Share calculated?
Cyclically Adjusted Book per Share is calculated from a company's financial statements. For Edwards Lifesciences (WBO:EWLS), the current Cyclically Adjusted Book per Share is €8.85 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Edwards Lifesciences (WBO:EWLS) Overvalued in 2026?

Based on GuruFocus' analysis, Edwards Lifesciences stock appears to be undervalued. The current stock price of €80.12 is trading 3.1% below its estimated GF Value™ of €82.70. GuruFocus considers Edwards Lifesciences to be Fairly Valued.

Key valuation signals for WBO:EWLS:

  • Cyclically Adjusted Book per Share: €8.85
  • GF Value™: €82.70 vs. price of €80.12 (3.1% below fair value)
  • GF Score™: 96/100 with 5 warning signs

No single metric tells the full story. See the WBO:EWLS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Edwards Lifesciences Business Description

Address One Edwards Way, Irvine, CA, USA, 92614
Spun off from Baxter International in 2000, Edwards Lifesciences designs, manufactures, and markets a range of medical devices and equipment for advanced stages of structural heart disease. It has established itself as a leader across key products, including surgical tissue heart valves, transcatheter aortic valves, and transcatheter mitral and tricuspid valve technologies. The firm derives about 60% of its total sales from outside the US.
96GF Score

Get the complete analysis for WBO:EWLS

Cyclically Adjusted Book per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€80.12
Price
€82.70
GF Value